As the Kazakh Health Ministry reported, nearly 74,500 people in Kazakhstan continue to receive treatment for the deadly disease.
Overall, while earlier an average of over 31,000 people were infected with a dangerous virus in seven days, now this figure is fixed at 25,000.
Deputy Prime Minister Yeraly Tugzhanov reviewed the work of the ‘Antigen’ enterprise in the Almaty region.
The team intends to check and analyze the production process of the QazVac domestic vaccine.
Studies are currently underway on the adaptation of Kazakh vaccine against the Delta variant.
Kazakh scientists are preparing an article with the research results, which will be published in a high-ranking scientific journal.
Infectious diseases hospitals in the Kazakh capital are being gradually closed due to a decrease in coronavirus incidence rate.
Almost 6.5 million people received the first component of COVID-19 vaccine, over 5 million received both.